Cargando…
P483: QUANTUM-FIRST TRIAL: FLT3-ITD–SPECIFIC MEASURABLE RESIDUAL DISEASE (MRD) CLEARANCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429678/ http://dx.doi.org/10.1097/01.HS9.0000968840.44654.8f |
| _version_ | 1785090773063041024 |
|---|---|
| author | Levis, Mark J Erba, Harry P. Montesinos, Pau Vrhovac, Radovan Patkowska, Elżbieta Kim, Hee-Je Zak, Pavel Wang, Po-Nan Connolly Rohrbach, Jaime E. Chang, Ken C.N. Hanyok, James Liu, LI Mostafa Kamel, Yasser Lesegretain, Arnaud Cortes, Jorge Sekeres, Mikkael A. Dombret, Hervé Amadori, Sergio Wang, Jianxiang Schlenk, Richard F. Perl, Alexander E. |
| author_facet | Levis, Mark J Erba, Harry P. Montesinos, Pau Vrhovac, Radovan Patkowska, Elżbieta Kim, Hee-Je Zak, Pavel Wang, Po-Nan Connolly Rohrbach, Jaime E. Chang, Ken C.N. Hanyok, James Liu, LI Mostafa Kamel, Yasser Lesegretain, Arnaud Cortes, Jorge Sekeres, Mikkael A. Dombret, Hervé Amadori, Sergio Wang, Jianxiang Schlenk, Richard F. Perl, Alexander E. |
| author_sort | Levis, Mark J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429678 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104296782023-08-17 P483: QUANTUM-FIRST TRIAL: FLT3-ITD–SPECIFIC MEASURABLE RESIDUAL DISEASE (MRD) CLEARANCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL Levis, Mark J Erba, Harry P. Montesinos, Pau Vrhovac, Radovan Patkowska, Elżbieta Kim, Hee-Je Zak, Pavel Wang, Po-Nan Connolly Rohrbach, Jaime E. Chang, Ken C.N. Hanyok, James Liu, LI Mostafa Kamel, Yasser Lesegretain, Arnaud Cortes, Jorge Sekeres, Mikkael A. Dombret, Hervé Amadori, Sergio Wang, Jianxiang Schlenk, Richard F. Perl, Alexander E. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429678/ http://dx.doi.org/10.1097/01.HS9.0000968840.44654.8f Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Levis, Mark J Erba, Harry P. Montesinos, Pau Vrhovac, Radovan Patkowska, Elżbieta Kim, Hee-Je Zak, Pavel Wang, Po-Nan Connolly Rohrbach, Jaime E. Chang, Ken C.N. Hanyok, James Liu, LI Mostafa Kamel, Yasser Lesegretain, Arnaud Cortes, Jorge Sekeres, Mikkael A. Dombret, Hervé Amadori, Sergio Wang, Jianxiang Schlenk, Richard F. Perl, Alexander E. P483: QUANTUM-FIRST TRIAL: FLT3-ITD–SPECIFIC MEASURABLE RESIDUAL DISEASE (MRD) CLEARANCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL |
| title | P483: QUANTUM-FIRST TRIAL: FLT3-ITD–SPECIFIC MEASURABLE RESIDUAL DISEASE (MRD) CLEARANCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL |
| title_full | P483: QUANTUM-FIRST TRIAL: FLT3-ITD–SPECIFIC MEASURABLE RESIDUAL DISEASE (MRD) CLEARANCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL |
| title_fullStr | P483: QUANTUM-FIRST TRIAL: FLT3-ITD–SPECIFIC MEASURABLE RESIDUAL DISEASE (MRD) CLEARANCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL |
| title_full_unstemmed | P483: QUANTUM-FIRST TRIAL: FLT3-ITD–SPECIFIC MEASURABLE RESIDUAL DISEASE (MRD) CLEARANCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL |
| title_short | P483: QUANTUM-FIRST TRIAL: FLT3-ITD–SPECIFIC MEASURABLE RESIDUAL DISEASE (MRD) CLEARANCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL |
| title_sort | p483: quantum-first trial: flt3-itd–specific measurable residual disease (mrd) clearance is associated with improved overall survival |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429678/ http://dx.doi.org/10.1097/01.HS9.0000968840.44654.8f |
| work_keys_str_mv | AT levismarkj p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT erbaharryp p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT montesinospau p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT vrhovacradovan p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT patkowskaelzbieta p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT kimheeje p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT zakpavel p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT wangponan p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT connollyrohrbachjaimee p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT changkencn p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT hanyokjames p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT liuli p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT mostafakamelyasser p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT lesegretainarnaud p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT cortesjorge p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT sekeresmikkaela p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT dombretherve p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT amadorisergio p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT wangjianxiang p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT schlenkrichardf p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival AT perlalexandere p483quantumfirsttrialflt3itdspecificmeasurableresidualdiseasemrdclearanceisassociatedwithimprovedoverallsurvival |